Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 12, 2010, Pages 2543-2547

  Whiley, David M ^a,b   Jacobsson, Susanne ^c   Tapsall, John W ^d   Nissen, Michael D ^a,b,e   Sloots, Theo P ^a,b,e   Unemo, Magnus ^c  

^a Queensland Children's Medical Research Institute   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d PRINCE OF WALES HOSPITAL   (Australia)

^e Pathology Queensland Central   (Australia)

Author keywords

Antimicrobial resistance; Extended spectrum cephalosporins; Gonorrhoea; penA; Third generation

Indexed keywords

CEFIXIME; CEFTRIAXONE;

AMINO ACID SEQUENCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE DELETION; GENE MUTATION; GENETIC RESISTANCE; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; CEFIXIME; CEFTRIAXONE; CEPHALOSPORIN RESISTANCE; FIMBRIAE PROTEINS; GONORRHEA; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; NEISSERIA GONORRHOEAE;

EID: 78149491898     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq377     Document Type: Article

References (11)

1. Tapsall JW, Ndowa F, Lewis DA et al. Meeting the public health challenge of multidrug-and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther 2009; 7: 821-34.
2. Zhao S, Duncan M, Tomberg J et al. Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2009; 53: 3744-51.
3. Whiley DM, Limnios EA, Ray S et al. Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob Agents Chemother 2007; 51: 3111-6.
4. Tomberg J, Unemo M, Davies C et al. Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations. Biochemistry 2010; 49: 8062-70.
5. Zhao S, Tobiason DM, Hu M et al. The penC mutation conferring antibiotic resistance in Neisseria gonorrhoeae arises from a mutation in the PilQ secretin that interferes with multimer stability. Mol Microbiol 2005; 57: 1238-51.
6. Chen CJ, Tobiason DM, Thomas CE et al. A mutant form of the Neisseria gonorrhoeae pilus secretin protein PilQ allows increased entry of heme and antimicrobial compounds. J Bacteriol 2004; 186: 730-9.
7. Tapsall JW, Phillips EA. The sensitivity of 173 Sydney isolates of Neisseria gonorrhoeae to cefpodoxime and other antibiotics used to treat gonorrhoea. Pathology 1995; 27:64-6.
8. Unemo M, Fasth O, Fredlund H et al. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother 2009; 63: 1142-51.
9. Kugelman G, Tapsall JW, Goire N et al. Simple, rapid, and inexpensive detection of Neisseria gonorrhoeae resistance mechanisms using heat-denatured isolates and SYBR green-based real-time PCR. Antimicrob Agents Chemother 2009; 53: 4211-6.
10. Helm RA, Barnhart MM, Seifert HS. pilQ missense mutations have diverse effects on PilQ multimer formation, piliation, and pilus function in Neisseria gonorrhoeae. J Bacteriol 2007; 189: 3198-207.
11. Hamrick TS, Dempsey JA, Cohen MS et al. Antigenic variation of gonococcal pilin expression in vivo: analysis of the strain FA1090 pilin repertoire and identification of the pilS gene copies recombining with pilE during experimental human infection. Microbiology 2001; 147: 839-49.